Carboxylesterase 1 as a Determinant of Clopidogrel Metabolism and Activation

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Glenn N. Levine, Eric Bates, James C. Blankenship et al. · Circulation · 2011 · 3.3K citations · Full text

Medicine, Cardiology, Surgery +14

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

Jessica L. Mega, Sandra Close, Stephen D. Wiviott et al. · New England Journal of Medicine · 2008 · 2.5K citations · Full text

Medicine, Cardiology, Pharmacology +17

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Glenn N. Levine, Eric Bates, James C. Blankenship et al. · Journal of the American College of Cardiology · 2011 · 2.2K citations

Medicine, Cardiology, Surgery +14

Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy

Alan R. Shuldiner · JAMA · 2009 · 1.5K citations · Full text

Medicine, Cardiology, Pharmacology +17

Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite

Miho Kazui, Yumi Nishiya, Tomoko Ishizuka et al. · Drug Metabolism and Disposition · 2009 · 821 citations

Medicine, Biochemistry, Pharmacology +17